About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Pennsylvania | 626 Studies

Clinical Trials Prostate CancerPennsylvania

Prostate Cancer Clinical Trials in Pennsylvania

Find 626 clinical trials for prostate cancer near Pennsylvania. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Pennsylvania

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 261-280 of 626 trials

Enrolling by invitationGenetic Education in BRCA FamiliesThe primary goal of this research is to test a web-based genetic education intervention that is designed to educate men and women from hereditary cancer families about the…NCT03544983·Washington D.C., District of Columbia and 3 others CompletedStudy of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerThis study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer.NCT00036556·Homewood, Alabama and 233 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedEffect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate CancerThe purpose of this study is to determine whether GTx 758 is effective in achieving and maintaining castrate testosterone levels in men with advanced prostate cancer.NCT01326312·Phoenix, Arizona and 35 others

CompletedA Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate CancerThe rationale of the study was to evaluate different degarelix dosing regimens for a three-month interval that was to produce and maintain castration in prostate cancer patients…NCT00116753·Homewood, Alabama and 55 others

CompletedTPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersThis is a phase 1/1b open label, multicenter dose escalation and dose expansion study to investigate the safety, tolerability and anti-tumor activity of TPST-1120, a small…NCT03829436·San Francisco, California and 10 others

CompletedEvaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossThis is a phase 3, randomized, double-blind, placebo-controlled study to evaluate new or worsening lens opacifications in men with non-metastatic prostate cancer receiving…NCT00925600·Anaheim, California and 171 others

TerminatedPositive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate CancerThe primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant…NCT01981109·Anchorage, Alaska and 57 others

CompletedDose Escalation and Efficacy Trial of GVAX® Prostate Cancer VaccineThe purpose of this study is to evaluate clinical and laboratory safety in patients receiving 4 different doses of GVAX® Prostate Cancer Vaccine in order to determine a maximum…NCT00140348·Laguna Woods, California and 11 others

RecruitingDistance-Based Exercise to Preserve Function and Prevent DisabilityThis clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to…NCT07059884·Dublin, California and 29 others

TerminatedGenetic Evaluation of Men (GEM)This is a prospective research registry and prospective genetic testing cohort study.NCT03076242·Abington, Pennsylvania and 2 others

CompletedImproving Decision-Making for Low Health Literate Prostate CA PatientsThis study used a randomized controlled trial to evaluate whether Healium (designed to target preference elicitation) is as efficacious as Healing Choices (a comprehensive…NCT05800483·Manhasset, New York and 1 other

UnknownEnzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerThis randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant…NCT01949337·Birmingham, Alabama and 538 others

CompletedSurgery Versus Internal Radiation in Treating Patients With Stage II Prostate CancerRATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells.NCT00023686·Little Rock, Arkansas and 35 others

CompletedStudy of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerThis study is being conducted to assess the safety and tolerability of relugolix with other agents approved for use in combination with androgen deprivation therapy (ADT) for a…NCT04666129·Tucson, Arizona and 15 others

RecruitingStudy of AZD0754 in Participants With Metastatic Prostate CancerThe purpose of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate cancer.NCT06267729·Duarte, California and 14 others

CompletedImaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer RecurrenceA prospective, Phase 3, multi center, single-arm, imaging study investigating the safety and diagnostic performance of rhPSMA 7.3 (18F) Positron Emission Tomography (PET) ligand…NCT04186845·Birmingham, Alabama and 27 others

RecruitingA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in Part 1 in…NCT07164443·La Jolla, California and 175 others

RecruitingProstate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL StudyThis study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive).NCT04472338·Duarte, California and 7 others

CompletedPaclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate CancerPhase II trial to study the effectiveness of combining paclitaxel and bryostatin 1 in treating patients who have metastatic prostate cancer that has not responded to hormone…NCT00005028·Baltimore, Maryland and 3 others

WithdrawnProspective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate CancerThe standard options for men with very low risk prostate cancer include active surveillance and the standard treatment options for low risk disease, i.e. radical prostatectomy…NCT02290366·Pittsburgh, Pennsylvania

PreviousPage 14 of 32Next

Other Conditions in Pennsylvania

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma